Press release
Savara Inc. (NASDAQ: SVRA) Investor Alert: Deadline in Lawsuit on November 7, 2025
A Deadline is coming up on November 7, 2025 in the lawsuit for certain investors in Savara Inc. (NASDAQ: SVRA).
Investors who purchased shares of Savara Inc. (NASDAQ: SVRA) have certain options and there are strict and short deadlines running. Deadline: November 7, 2025. Savara Inc. (NASDAQ: SVRA) stockholders should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
According to the complaint filed in the U.S. District Court for the Eastern District of Pennsylvania the plaintiff alleges on behalf of purchasers of Savara Inc. (NASDAQ: SVRA) common shares between March 7, 2024 and May 23, 2025, that the defendants violated Federal Securities Laws. More specifically, the plaintiff claims that between March 7, 2024 and May 23, 2025, the Defendants failed to disclose to investors that the MOLBREEVI BLA lacked sufficient information regarding MOLBREEVI's chemistry, manufacturing, and/or controls, that accordingly, the FDA was unlikely to approve the MOLBREEVI BLA in its current form, that the foregoing made it unlikely that Savara would complete its submission of the MOLBREEVI BLA within the timeframe it had represented to investors, that the delay in MOLBREEVI's regulatory approval increased the likelihood that the Company would need to raise additional capital, and that as a result, Defendants' positive statements about the Company's business, operations, and prospects were materially misleading and/or lacked a reasonable basis at all relevant times.
Those who purchased shares of Savara Inc. (NASDAQ: SVRA) have certain options and should contact the Shareholders Foundation.
Contact:
Michael Daniels
Shareholders Foundation, Inc.
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108
Tel: +1-(858)-779-1554
E-Mail: mail@shareholdersfoundation.com
About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, and an investor advocacy group, which does research related to shareholder issues and informs investors of securities lawsuits, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Savara Inc. (NASDAQ: SVRA) Investor Alert: Deadline in Lawsuit on November 7, 2025 here
News-ID: 4245738 • Views: …
More Releases from Shareholders Foundation, Inc.
Tronox Holdings plc (NYSE: TROX) Investor Alert: Deadline in Lawsuit on November …
A deadline is coming up on November 3, 2025 in the lawsuit filed for certain investors of Tronox Holdings plc (NYSE: TROX) over alleged securities laws violations by Tronox Holdings plc.
Investors who purchased shares of Tronox Holdings plc (NYSE: TROX) have certain options and there are strict and short deadlines running. Deadline: November 3, 2025. Tronox Holdings plc (NYSE: TROX) stockholders should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call…
Lawsuit Alert: Investors who lost money with shares of WPP plc (NYSE: WPP) shoul …
An investor, who purchased shares of WPP plc (NYSE: WPP), filed a lawsuit in the U.S. over alleged violations of Federal Securities Laws by WPP plc (NYSE: WPP in connection with certain allegedly false and misleading statements made between February 27, 2025, to July 8, 2025.
Investors who purchased a significant amount of shares of WPP plc (NYSE: WPP) between February 27, 2025, to July 8, 2025, have certain options and…
Lawsuit filed for Investors who lost money with shares of aTyr Pharma, Inc. (NAS …
An investor, who purchased shares of aTyr Pharma, Inc. (NASDAQ: ATYR), filed a lawsuit over alleged violations of Federal Securities Laws by aTyr Pharma, Inc. in connection with certain allegedly false and misleading statements.
Investors who purchased shares of aTyr Pharma, Inc. (NASDAQ: ATYR) have certain options and for certain investors are short and strict deadlines running. Deadline: December 8, 2025. NASDAQ: ATYR investors should contact the Shareholders Foundation at…
Semler Scientific, Inc. (NASDAQ: SMLR) Investor Alert: Deadline in Lawsuit on Oc …
A deadline is coming up on October 28, 2025 in the lawsuit filed for certain investors of Semler Scientific, Inc. (NASDAQ: SMLR) over alleged securities laws violations by Semler Scientific, Inc.
Investors who purchased shares of Semler Scientific, Inc. (NASDAQ: SMLR) have certain options and there are strict and short deadlines running. Deadline: October 28, 2025. Semler Scientific, Inc. (NASDAQ: SMLR) stockholders should contact the Shareholders Foundation at mail@shareholdersfoundation.com or…
More Releases for Savara
Lawsuit filed for Investors who lost money with shares of Savara Inc. (NASDAQ: S …
An investor, who purchased shares of Savara Inc. (NASDAQ: SVRA), filed a lawsuit over alleged violations of Federal Securities Laws by Savara Inc. in connection with certain allegedly false and misleading statements.
Investors who purchased shares of Savara Inc. (NASDAQ: SVRA) have certain options and for certain investors are short and strict deadlines running. Deadline: November 7, 2025. NASDAQ: SVRA investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858)…
Autoimmune Pulmonary Alveolar Proteinosis Market to Expand Significantly by 2032 …
The Key Autoimmune Pulmonary Alveolar Proteinosis Companies in the market include - Savara Inc., and others.
DelveInsight's "Autoimmune Pulmonary Alveolar Proteinosis Market Insights, Epidemiology, and Market Forecast-2034 report offers an in-depth understanding of the Autoimmune Pulmonary Alveolar Proteinosis, historical and forecasted epidemiology as well as the Autoimmune Pulmonary Alveolar Proteinosis market trends in the United States, EU4 (Germany, Spain, Italy, France) the United Kingdom and Japan.
To Know in detail about the…
Autoimmune Pulmonary Alveolar Proteinosis Market | Savara Pharmaceuticals, Bridg …
DelveInsight's "Autoimmune Pulmonary Alveolar Proteinosis Market Insights, Epidemiology, and Market Forecast-2034" report delivers an in-depth understanding of Autoimmune Pulmonary Alveolar Proteinosis, historical and forecasted epidemiology as well as the Autoimmune Pulmonary Alveolar Proteinosis market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom), and Japan.
The Autoimmune Pulmonary Alveolar Proteinosis market report provides current treatment practices, emerging drugs, the market share of the individual therapies, and…
Autoimmune Pulmonary Alveolar Proteinosis (aPAP) Market to Witness Upsurge in Gr …
DelveInsight's "Autoimmune Pulmonary Alveolar Proteinosis Market Insights, Epidemiology, and Market Forecast-2034″ report offers an in-depth understanding of the Autoimmune Pulmonary Alveolar Proteinosis, historical and forecasted epidemiology as well as the Autoimmune Pulmonary Alveolar Proteinosis market trends in the United States, EU4 (Germany, Spain, Italy, France) the United Kingdom and Japan.
To Know in detail about the Autoimmune Pulmonary Alveolar Proteinosis market outlook, drug uptake, treatment scenario and epidemiology trends, Click…
Autoimmune Pulmonary Alveolar Proteinosis (aPAP) Market to Observe Impressive Gr …
DelveInsight's "Autoimmune Pulmonary Alveolar Proteinosis Market Insights, Epidemiology, and Market Forecast-2032″ report offers an in-depth understanding of the Autoimmune Pulmonary Alveolar Proteinosis, historical and forecasted epidemiology as well as the Autoimmune Pulmonary Alveolar Proteinosis market trends in the United States, EU4 (Germany, Spain, Italy, France) the United Kingdom and Japan.
To Know in detail about the Autoimmune Pulmonary Alveolar Proteinosis market outlook, drug uptake, treatment scenario and epidemiology trends, Click…
Autoimmune Pulmonary Alveolar Proteinosis Market | Savara Pharmaceuticals, Bridg …
DelveInsight's "Autoimmune Pulmonary Alveolar Proteinosis Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of Autoimmune Pulmonary Alveolar Proteinosis, historical and forecasted epidemiology as well as the Autoimmune Pulmonary Alveolar Proteinosis market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom), and Japan.
The Autoimmune Pulmonary Alveolar Proteinosis market report provides current treatment practices, emerging drugs, the market share of the individual therapies, and…
